Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 103 entries
Sorted by: Best Match Show Resources per page
Isolated Intraocular Rosai-Dorfman Disease.

Ocular oncology and pathology

Fogt F, Rüediger T, Augustin AJ, Frank DM, Rosenwald A, Wellmann A, Lee V.
PMID: 31768365
Ocul Oncol Pathol. 2019 Oct;5(6):418-423. doi: 10.1159/000497185. Epub 2019 Apr 10.

BACKGROUND/AIMS: To report a case of Rosai-Dorfman disease (RDD) presenting as a solitary, choroidal mass, initially suspicious for uveal melanoma, in a 72-year-old woman.METHODS: Retrospective case report of a single patient.RESULTS: A 72-year-old woman presented with sudden vision loss...

Cite
Fogt F, Rüediger T, Augustin AJ, et al. Isolated Intraocular Rosai-Dorfman Disease. Ocul Oncol Pathol. 2019;5(6):418-423doi: 10.1159/000497185.
Fogt, F., Rüediger, T., Augustin, A. J., Frank, D. M., Rosenwald, A., Wellmann, A., & Lee, V. (2019). Isolated Intraocular Rosai-Dorfman Disease. Ocular oncology and pathology, 5(6), 418-423. https://doi.org/10.1159/000497185
Fogt, Franz, et al. "Isolated Intraocular Rosai-Dorfman Disease." Ocular oncology and pathology vol. 5,6 (2019): 418-423. doi: https://doi.org/10.1159/000497185
Fogt F, Rüediger T, Augustin AJ, Frank DM, Rosenwald A, Wellmann A, Lee V. Isolated Intraocular Rosai-Dorfman Disease. Ocul Oncol Pathol. 2019 Oct;5(6):418-423. doi: 10.1159/000497185. Epub 2019 Apr 10. PMID: 31768365; PMCID: PMC6872985.
Copy Download .nbib Format: NLM
A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type.

Annals of hematology

Rosenfeldt MT, Hartmann EM, Leng C, Rosenwald A, Anagnostopoulos I.
PMID: 32683458
Ann Hematol. 2021 Oct;100(10):2635-2637. doi: 10.1007/s00277-020-04174-4. Epub 2020 Jul 19.

No abstract available.

Cite
Rosenfeldt MT, Hartmann EM, Leng C, et al. A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type. Ann Hematol. 2020;100(10):2635-2637doi: 10.1007/s00277-020-04174-4.
Rosenfeldt, M. T., Hartmann, E. M., Leng, C., Rosenwald, A., & Anagnostopoulos, I. (2021). A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type. Annals of hematology, 100(10), 2635-2637. https://doi.org/10.1007/s00277-020-04174-4
Rosenfeldt, Mathias T, et al. "A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type." Annals of hematology vol. 100,10 (2021): 2635-2637. doi: https://doi.org/10.1007/s00277-020-04174-4
Rosenfeldt MT, Hartmann EM, Leng C, Rosenwald A, Anagnostopoulos I. A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type. Ann Hematol. 2021 Oct;100(10):2635-2637. doi: 10.1007/s00277-020-04174-4. Epub 2020 Jul 19. PMID: 32683458; PMCID: PMC8440277.
Copy Download .nbib Format: NLM
Cutaneous epithelioid hemangiomas show somatic mutations in the MAPK pathway.

The British journal of dermatology

Maurus K, Kosnopfel C, Kneitz H, Appenzeller S, Schrama D, Glutsch V, Roth S, Gerhard-Hartmann E, Rosenfeldt M, Möhrmann L, Fröhlich M, Hübschmann D, Stenzinger A, Glimm H, Fröhling S, Goebeler M, Rosenwald A, Kutzner H, Schilling B.
PMID: 34726260
Br J Dermatol. 2021 Nov 02; doi: 10.1111/bjd.20869. Epub 2021 Nov 02.

BACKGROUND: Epithelioid hemangioma (EH) arising from the skin is a benign vascular tumor with marked inflammatory cell infiltration, which exhibits a high tendency to persist and frequently recurs after resection. So far, the underlying pathogenesis is largely elusive.OBJECTIVES: To...

Cite
Maurus K, Kosnopfel C, Kneitz H, et al. Cutaneous epithelioid hemangiomas show somatic mutations in the MAPK pathway. Br J Dermatol. 2021;doi: 10.1111/bjd.20869.
Maurus, K., Kosnopfel, C., Kneitz, H., Appenzeller, S., Schrama, D., Glutsch, V., Roth, S., Gerhard-Hartmann, E., Rosenfeldt, M., Möhrmann, L., Fröhlich, M., Hübschmann, D., Stenzinger, A., Glimm, H., Fröhling, S., Goebeler, M., Rosenwald, A., Kutzner, H., & Schilling, B. (2021). Cutaneous epithelioid hemangiomas show somatic mutations in the MAPK pathway. The British journal of dermatology, . https://doi.org/10.1111/bjd.20869
Maurus, K, et al. "Cutaneous epithelioid hemangiomas show somatic mutations in the MAPK pathway." The British journal of dermatology vol. (2021). doi: https://doi.org/10.1111/bjd.20869
Maurus K, Kosnopfel C, Kneitz H, Appenzeller S, Schrama D, Glutsch V, Roth S, Gerhard-Hartmann E, Rosenfeldt M, Möhrmann L, Fröhlich M, Hübschmann D, Stenzinger A, Glimm H, Fröhling S, Goebeler M, Rosenwald A, Kutzner H, Schilling B. Cutaneous epithelioid hemangiomas show somatic mutations in the MAPK pathway. Br J Dermatol. 2021 Nov 02; doi: 10.1111/bjd.20869. Epub 2021 Nov 02. PMID: 34726260.
Copy Download .nbib Format: NLM
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.

HemaSphere

Houot R, Poeschel V, Altmann B, Angel S, Thurner L, Illmer T, Andre M, Dreyling M, Maisonneuve H, Tilly H, Mayer S, Casasnovas O, Le Gouill S, Offner F, Cartron G, Kerkhoff A, Weber T, Hoffmann J, Ziepert M, Klapper W, Itti E, Hellwig D, Natchkebia G, de Leval L, Rosenwald A, Haioun C, Dercle L, Gaulard P, Held G.
PMID: 35028526
Hemasphere. 2022 Jan 10;6(2):e672. doi: 10.1097/HS9.0000000000000672. eCollection 2022 Feb.

Supplemental Digital Content is available in the text.

Cite
Houot R, Poeschel V, Altmann B, et al. Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. Hemasphere. 2022;6(2):e672doi: 10.1097/HS9.0000000000000672.
Houot, R., Poeschel, V., Altmann, B., Angel, S., Thurner, L., Illmer, T., Andre, M., Dreyling, M., Maisonneuve, H., Tilly, H., Mayer, S., Casasnovas, O., Le Gouill, S., Offner, F., Cartron, G., Kerkhoff, A., Weber, T., Hoffmann, J., Ziepert, M., Klapper, W., Itti, E., Hellwig, D., Natchkebia, G., de Leval, L., Rosenwald, A., Haioun, C., Dercle, L., Gaulard, P., & Held, G. (2022). Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. HemaSphere, 6(2), e672. https://doi.org/10.1097/HS9.0000000000000672
Houot, Roch, et al. "Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma." HemaSphere vol. 6,2 (2022): e672. doi: https://doi.org/10.1097/HS9.0000000000000672
Houot R, Poeschel V, Altmann B, Angel S, Thurner L, Illmer T, Andre M, Dreyling M, Maisonneuve H, Tilly H, Mayer S, Casasnovas O, Le Gouill S, Offner F, Cartron G, Kerkhoff A, Weber T, Hoffmann J, Ziepert M, Klapper W, Itti E, Hellwig D, Natchkebia G, de Leval L, Rosenwald A, Haioun C, Dercle L, Gaulard P, Held G. Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. Hemasphere. 2022 Jan 10;6(2):e672. doi: 10.1097/HS9.0000000000000672. eCollection 2022 Feb. PMID: 35028526; PMCID: PMC8751801.
Copy Download .nbib Format: NLM
[No title available]

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Kraus S, Dierks A, Rasche L, Kertels O, Kircher M, Schirbel A, Zovko J, Steinbrunn T, Tibes R, Wester HJ, Buck AK, Einsele H, Kortüm KM, Rosenwald A, Lapa C.
PMID: 34049979
J Nucl Med. 2022 Jan;63(1):96-99. doi: 10.2967/jnumed.121.262206. Epub 2021 May 28.

C-X-C motif chemokine receptor 4 (CXCR4) is an attractive target for cancer diagnosis and treatment, as it is overexpressed in many solid and hematologic malignancies. This study investigated the feasibility of CXCR4-directed imaging with PET/CT using

Cite
Kraus S, Dierks A, Rasche L, et al. . J Nucl Med. 2021;63(1):96-99doi: 10.2967/jnumed.121.262206.
Kraus, S., Dierks, A., Rasche, L., Kertels, O., Kircher, M., Schirbel, A., Zovko, J., Steinbrunn, T., Tibes, R., Wester, H. J., Buck, A. K., Einsele, H., Kortüm, K. M., Rosenwald, A., & Lapa, C. (2022). . Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 63(1), 96-99. https://doi.org/10.2967/jnumed.121.262206
Kraus, Sabrina, et al. "." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 63,1 (2022): 96-99. doi: https://doi.org/10.2967/jnumed.121.262206
Kraus S, Dierks A, Rasche L, Kertels O, Kircher M, Schirbel A, Zovko J, Steinbrunn T, Tibes R, Wester HJ, Buck AK, Einsele H, Kortüm KM, Rosenwald A, Lapa C. . J Nucl Med. 2022 Jan;63(1):96-99. doi: 10.2967/jnumed.121.262206. Epub 2021 May 28. PMID: 34049979.
Copy Download .nbib Format: NLM
Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma.

Blood cancer journal

Leich E, Schreder M, Pischimarov J, Stühmer T, Steinbrunn T, Rudelius M, Brünnert D, Chatterjee M, Langer C, Keppler S, Heredia-Guerrero SC, Einsele H, Knop S, Bargou RC, Rosenwald A.
PMID: 33664224
Blood Cancer J. 2021 Mar 04;11(3):51. doi: 10.1038/s41408-021-00442-2.

No abstract available.

Cite
Leich E, Schreder M, Pischimarov J, et al. Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma. Blood Cancer J. 2021;11(3):51doi: 10.1038/s41408-021-00442-2.
Leich, E., Schreder, M., Pischimarov, J., Stühmer, T., Steinbrunn, T., Rudelius, M., Brünnert, D., Chatterjee, M., Langer, C., Keppler, S., Heredia-Guerrero, S. C., Einsele, H., Knop, S., Bargou, R. C., & Rosenwald, A. (2021). Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma. Blood cancer journal, 11(3), 51. https://doi.org/10.1038/s41408-021-00442-2
Leich, Ellen, et al. "Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma." Blood cancer journal vol. 11,3 (2021): 51. doi: https://doi.org/10.1038/s41408-021-00442-2
Leich E, Schreder M, Pischimarov J, Stühmer T, Steinbrunn T, Rudelius M, Brünnert D, Chatterjee M, Langer C, Keppler S, Heredia-Guerrero SC, Einsele H, Knop S, Bargou RC, Rosenwald A. Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma. Blood Cancer J. 2021 Mar 04;11(3):51. doi: 10.1038/s41408-021-00442-2. PMID: 33664224; PMCID: PMC7933144.
Copy Download .nbib Format: NLM
Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach.

Histopathology

Fichtner A, Richter A, Filmar S, Kircher S, Rosenwald A, Küffer S, Nettersheim D, Oing C, Marx A, Ströbel P, Bremmer F.
PMID: 34506648
Histopathology. 2021 Sep 10; doi: 10.1111/his.14560. Epub 2021 Sep 10.

AIMS: Primary mediastinal germ cell tumours (PMGCTs) are rare mediastinal neoplasms, and their diagnosis can be challenging, owing to small biopsy samples. The aim of this study was to develop a diagnostic algorithm using immunohistochemical staining, with a focus...

Cite
Fichtner A, Richter A, Filmar S, et al. Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach. Histopathology. 2021;doi: 10.1111/his.14560.
Fichtner, A., Richter, A., Filmar, S., Kircher, S., Rosenwald, A., Küffer, S., Nettersheim, D., Oing, C., Marx, A., Ströbel, P., & Bremmer, F. (2021). Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach. Histopathology, . https://doi.org/10.1111/his.14560
Fichtner, Alexander, et al. "Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach." Histopathology vol. (2021). doi: https://doi.org/10.1111/his.14560
Fichtner A, Richter A, Filmar S, Kircher S, Rosenwald A, Küffer S, Nettersheim D, Oing C, Marx A, Ströbel P, Bremmer F. Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach. Histopathology. 2021 Sep 10; doi: 10.1111/his.14560. Epub 2021 Sep 10. PMID: 34506648.
Copy Download .nbib Format: NLM
Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines.

Cancers

Weißbach S, Heredia-Guerrero SC, Barnsteiner S, Großhans L, Bodem J, Starz H, Langer C, Appenzeller S, Knop S, Steinbrunn T, Rost S, Einsele H, Bargou RC, Rosenwald A, Stühmer T, Leich E.
PMID: 32079091
Cancers (Basel). 2020 Feb 16;12(2). doi: 10.3390/cancers12020455.

Approximately 20% of multiple myeloma (MM) cases harbor a point mutation in

Cite
Weißbach S, Heredia-Guerrero SC, Barnsteiner S, et al. Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines. Cancers (Basel). 2020;12(2)doi: 10.3390/cancers12020455.
Weißbach, S., Heredia-Guerrero, S. C., Barnsteiner, S., Großhans, L., Bodem, J., Starz, H., Langer, C., Appenzeller, S., Knop, S., Steinbrunn, T., Rost, S., Einsele, H., Bargou, R. C., Rosenwald, A., Stühmer, T., & Leich, E. (2020). Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines. Cancers, 12(2), . https://doi.org/10.3390/cancers12020455
Weißbach, Susann, et al. "Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines." Cancers vol. 12,2 (2020). doi: https://doi.org/10.3390/cancers12020455
Weißbach S, Heredia-Guerrero SC, Barnsteiner S, Großhans L, Bodem J, Starz H, Langer C, Appenzeller S, Knop S, Steinbrunn T, Rost S, Einsele H, Bargou RC, Rosenwald A, Stühmer T, Leich E. Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines. Cancers (Basel). 2020 Feb 16;12(2). doi: 10.3390/cancers12020455. PMID: 32079091; PMCID: PMC7072554.
Copy Download .nbib Format: NLM
Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients.

JID innovations

Wobser M, Roth S, Appenzeller S, Kneitz H, Goebeler M, Geissinger E, Rosenwald A, Maurus K.
PMID: 34909731
JID Innov. 2021 Jun 15;1(3):100034. doi: 10.1016/j.xjidi.2021.100034. eCollection 2021 Sep.

The emergence of a common progenitor cell has been postulated for the association of CD30-positive lymphoproliferative disease (LPD) and mycosis fungoides (MF) within the same patient. Up to now, no comprehensive analysis has yet addressed the genetic profiles of...

Cite
Wobser M, Roth S, Appenzeller S, et al. Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID Innov. 2021;1(3):100034doi: 10.1016/j.xjidi.2021.100034.
Wobser, M., Roth, S., Appenzeller, S., Kneitz, H., Goebeler, M., Geissinger, E., Rosenwald, A., & Maurus, K. (2021). Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID innovations, 1(3), 100034. https://doi.org/10.1016/j.xjidi.2021.100034
Wobser, Marion, et al. "Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients." JID innovations vol. 1,3 (2021): 100034. doi: https://doi.org/10.1016/j.xjidi.2021.100034
Wobser M, Roth S, Appenzeller S, Kneitz H, Goebeler M, Geissinger E, Rosenwald A, Maurus K. Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID Innov. 2021 Jun 15;1(3):100034. doi: 10.1016/j.xjidi.2021.100034. eCollection 2021 Sep. PMID: 34909731; PMCID: PMC8659398.
Copy Download .nbib Format: NLM
Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.

British journal of haematology

Richter J, John K, Staiger AM, Rosenwald A, Kurz K, Michgehl U, Ott G, Franzenburg S, Kohler C, Finger J, Oschlies I, Paul U, Siebert R, Spang R, Burkhardt B, Klapper W.
PMID: 34617271
Br J Haematol. 2021 Oct 06; doi: 10.1111/bjh.17874. Epub 2021 Oct 06.

Sporadic Burkitt lymphoma (BL) is the most frequent tumour of children and adolescents but a rare subtype of lymphomas in adults. To date most molecular data have been obtained from lymphomas arising in the young. Recently, Epstein-Barr virus (EBV)...

Cite
Richter J, John K, Staiger AM, et al. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Br J Haematol. 2021;doi: 10.1111/bjh.17874.
Richter, J., John, K., Staiger, A. M., Rosenwald, A., Kurz, K., Michgehl, U., Ott, G., Franzenburg, S., Kohler, C., Finger, J., Oschlies, I., Paul, U., Siebert, R., Spang, R., Burkhardt, B., & Klapper, W. (2021). Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. British journal of haematology, . https://doi.org/10.1111/bjh.17874
Richter, Julia, et al. "Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features." British journal of haematology vol. (2021). doi: https://doi.org/10.1111/bjh.17874
Richter J, John K, Staiger AM, Rosenwald A, Kurz K, Michgehl U, Ott G, Franzenburg S, Kohler C, Finger J, Oschlies I, Paul U, Siebert R, Spang R, Burkhardt B, Klapper W. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Br J Haematol. 2021 Oct 06; doi: 10.1111/bjh.17874. Epub 2021 Oct 06. PMID: 34617271.
Copy Download .nbib Format: NLM
Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients.

JID innovations

Wobser M, Roth S, Appenzeller S, Kneitz H, Goebeler M, Geissinger E, Rosenwald A, Maurus K.
PMID: 34909731
JID Innov. 2021 Jun 15;1(3):100034. doi: 10.1016/j.xjidi.2021.100034. eCollection 2021 Sep.

The emergence of a common progenitor cell has been postulated for the association of CD30-positive lymphoproliferative disease (LPD) and mycosis fungoides (MF) within the same patient. Up to now, no comprehensive analysis has yet addressed the genetic profiles of...

Cite
Wobser M, Roth S, Appenzeller S, et al. Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID Innov. 2021;1(3):100034doi: 10.1016/j.xjidi.2021.100034.
Wobser, M., Roth, S., Appenzeller, S., Kneitz, H., Goebeler, M., Geissinger, E., Rosenwald, A., & Maurus, K. (2021). Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID innovations, 1(3), 100034. https://doi.org/10.1016/j.xjidi.2021.100034
Wobser, Marion, et al. "Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients." JID innovations vol. 1,3 (2021): 100034. doi: https://doi.org/10.1016/j.xjidi.2021.100034
Wobser M, Roth S, Appenzeller S, Kneitz H, Goebeler M, Geissinger E, Rosenwald A, Maurus K. Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID Innov. 2021 Jun 15;1(3):100034. doi: 10.1016/j.xjidi.2021.100034. eCollection 2021 Sep. PMID: 34909731; PMCID: PMC8659398.
Copy Download .nbib Format: NLM
Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries.

Frontiers in oncology

Marquardt A, Solimando AG, Kerscher A, Bittrich M, Kalogirou C, Kübler H, Rosenwald A, Bargou R, Kollmannsberger P, Schilling B, Meierjohann S, Krebs M.
PMID: 33791209
Front Oncol. 2021 Mar 15;11:621278. doi: 10.3389/fonc.2021.621278. eCollection 2021.

No abstract available.

Cite
Marquardt A, Solimando AG, Kerscher A, et al. Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries. Front Oncol. 2021;11:621278doi: 10.3389/fonc.2021.621278.
Marquardt, A., Solimando, A. G., Kerscher, A., Bittrich, M., Kalogirou, C., Kübler, H., Rosenwald, A., Bargou, R., Kollmannsberger, P., Schilling, B., Meierjohann, S., & Krebs, M. (2021). Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries. Frontiers in oncology, 11621278. https://doi.org/10.3389/fonc.2021.621278
Marquardt, André, et al. "Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries." Frontiers in oncology vol. 11 (2021): 621278. doi: https://doi.org/10.3389/fonc.2021.621278
Marquardt A, Solimando AG, Kerscher A, Bittrich M, Kalogirou C, Kübler H, Rosenwald A, Bargou R, Kollmannsberger P, Schilling B, Meierjohann S, Krebs M. Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries. Front Oncol. 2021 Mar 15;11:621278. doi: 10.3389/fonc.2021.621278. eCollection 2021. PMID: 33791209; PMCID: PMC8005734.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 103 entries